Synthetic Biology

Technologies to create new organisms, including microbes and plants, with valuable capabilities for various applications.

LUX TAKE:

The chemical industry and its customers are looking for alternatives to fossil feedstock, including CO2 and sugar. Synthetic biology has potential to lead this disruption, as the technology can develop microorganisms to convert bio-based feedstocks into products for the traditional petrochemical industry and in applications such as agrifood and health where consumers desire naturally derived ...

Data last updated on April 01, 2020

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent synthetic biology developments.

News Commentaries

Conagen announces strategic investment from Sumitomo Chemical, targeting "sustainable" chemicals (April 1, 2020)

Nohbo raises $3 million in seed funding for its dissolvable shampoo drops (March 31, 2020)

New Lux Content

Genecis (March 31, 2020)

The Digital Transformation of Chemicals and Materials (March 30, 2020)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	ATUM, Genomatica, Amyris, Metabolic Explorer, Global Bioenergies, Ginkgo Bioworks, SyntheZyme, Isobionics, Lygos, Zymergen, Industrial Microbes, Twist Bioscience, Ecovia Renewables, Manus Bio, DMC, Conagen, Spidey Tek, enEvolv, Checkerspot, Tierra Biosciences, Cysbio

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978